Abbott bolsters diagnostics portfolio with up to $23 billion buyout of Exact Sciences
20/11/2025 12:33
Nov 20 (Reuters) - Abbott ABT.N said on Thursday it would buy cancer test maker Exact Sciences EXAS.O in up to $23 billion deal, bolstering the medical device maker's diagnostics business. (Reporting by Padmanabhan Ananthan and Siddhi Mahatole in Bengaluru; Editing by Shilpi Majumdar) ((Padmanabhan.Ananthan@thomsonreuters.com;))
Recent news on Abbott Laboratories
See all newsBrief: FDA Approves Abbott HIV Combo Next Assay
Press Digest: Wall Street Journal - June 29
US DOJ closes criminal probe into Abbott over baby formula plant, WSJ reports (updated)
US DOJ closes criminal probe into Abbott over baby formula plant, WSJ reports
Factbox: Major deals involving US drugmakers and biotechs over the past decade